Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Perrigo Company (Nasdaq: PRGO) hit a new 52-week high Tuesday as it is currently trading at $120.88, above its previous 52-week high of $120.78 with 228,520 shares traded as of 12:05 p.m. ET. Average volume has been 737,800 shares over the past 30 days. Perrigo has a market cap of $11.16 billion and is part of the health care sector and drugs industry. Shares are up 14.3% year to date as of the close of trading on Monday. Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API) worldwide. The company has a P/E ratio of 25.8, above the S&P 500 P/E ratio of 17.7.